Loading...
Docoh

Exelixis (EXEL)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
ESG term mentions
In last year of SEC filings
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
(a) The Annual Meeting was held on May 25, 2022 via live webcast.
(b) The results of the matters submitted to a stockholder vote at the Annual Meeting were as follows:
1.Election of Directors: Exelixis stockholders elected the following 11 directors to serve until the next annual meeting of stockholders in 2023, and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal:
FORAGAINSTABSTAINBROKER
NON-VOTES
Carl B. Feldbaum, Esq.243,679,225 6,908,837 288,876 29,412,598
Maria C. Freire, Ph.D.246,730,733 3,900,513 245,692 29,412,598
Alan M. Garber, M.D., Ph.D.227,190,127 23,396,603 290,208 29,412,598
Vincent T. Marchesi, M.D., Ph.D.235,368,545 15,234,650 273,743 29,412,598
Michael M. Morrissey, Ph.D.247,205,304 3,402,417 269,217 29,412,598
Stelios Papadopoulos, Ph.D.227,228,455 21,124,945 2,523,538 29,412,598
George Poste, DVM, Ph.D., FRS246,766,336 3,839,884 270,718 29,412,598
Julie Anne Smith248,905,885 1,692,784 278,269 29,412,598
Lance Willsey, M.D.236,109,321 14,473,623 293,994 29,412,598
Jacqueline Wright246,675,548 3,911,936 289,454 29,412,598
Jack L. Wyszomierski231,827,138 18,755,844 293,956 29,412,598

2. Ratification of Ernst & Young LLP as Exelixis' independent registered public accounting firm: Exelixis stockholders ratified the selection of Ernst & Young LLP as Exelixis’ independent registered public accounting firm for the fiscal year ending December 30, 2022.
FORAGAINSTABSTAINBROKER
NON-VOTES
275,952,895 3,992,183 344,458 0

3. Approval of the 2017 Plan: Exelixis stockholders approved the 2017 Plan.
FORAGAINSTABSTAINBROKER
NON-VOTES
235,050,854 15,623,198 202,886 29,412,598

4. Approval, on an advisory basis, of Exelixis’ named executive officers, as disclosed in the Proxy Statement (Say on Pay): Exelixis stockholders approved the Say on Pay proposal.
FORAGAINSTABSTAINBROKER
NON-VOTES
243,569,589 6,255,051 1,052,298 29,412,598